Menu
Menu
Ocrevus is a prescription medicine used to treat:
Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults
Primary progressive MS, in adults
Ocrevus is an intravenous infusion that is given every 6 months.
Your first dose will be split into 2 infusions, 2 weeks apart. Your appointment may take 4-6 hours due to premedication before your infusion, as well as 1 hour of monitoring post-infusion.
Every dose after your first will be given as one single infusion six months apart, each lasting 2-4 hours.
If you haven’t had any serious infusion reactions with previous Ocrevus infusions, a shorter infusion option is available.
1 Hour of Monitoring After Infusion
Infusion reactions are a common side effect of Ocrevus. You will be monitored during your infusion and for at least 1 hour after each infusion for signs and symptoms of an infusion reaction which may include: Itchy skin, rash, hives, tiredness, coughing or wheezing, trouble breathing, throat irritation or pain, feeling faint, fever, redness on your face (flushing), nausea, headache, swelling of the throat, dizziness, shortness of breath, fatigue, fast heart beat
Ocrevus can cause serious side effects including infection.
Although no cases have been seen with Ocrevus treatment in clinical trials, PML (Progressive Multifocal Leukoencephalopathy) may happen with Ocrevus.
Before starting treatment with OCREVUS, your healthcare provider will do blood tests to check for hepatitis B viral infection.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Ocrevus website.
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.
